New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
12:50 EDTPHH, NKTR, MET, SVU, GAMEHigh option volume stocks: PHH NKTR MET SVU GAME
News For PHH;NKTR;MET;SVU;GAME From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 30, 2014
15:06 EDTMETFed will begin study to evaluate impact of capital rules on insurance companies
Subscribe for More Information
September 29, 2014
17:29 EDTSVUSupervalu down 1% after hours following new malware attack, data breach
Subscribe for More Information
17:19 EDTSVUSupervalu discovers different Malware on some of its point of sale systems
Subscribe for More Information
September 26, 2014
08:05 EDTGAMEShanda Games reports Q2 EPS 20c
Subscribe for More Information
07:31 EDTNKTRNektar announces MOVENTIG receives positive CHMP opinion in EU
Subscribe for More Information
September 24, 2014
10:35 EDTNKTRHigh option volume stocks
Subscribe for More Information
September 19, 2014
09:01 EDTNKTRNektar presents preclinical data on kappa opioid receptor
Nektar announced results from preclinical studies characterizing the analgesic profiles of a series of the company's internally-discovered oral, peripherally-acting kappa opioid receptor agonist molecules. The analgesic properties of kappa receptor agonism are well described in the medical literature.1,2 Kappa opioid receptors are expressed in the peripheral nervous system as well as in the central nervous system, and activation of these receptors at both sites has been shown to result in a reduction in pain and inflammation in a wide range of preclinical models. However, the therapeutic use of kappa receptor agonists has been limited because activation of these receptors in the CNS is associated with significant dysphoria and other unwanted side effects.
September 17, 2014
14:41 EDTMETMetLife management to meet with Sterne Agee
Subscribe for More Information
08:50 EDTNKTRNektar Movantik approval positive, says Roth Capital
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use